Brand Asset Management Group, Inc. Amgen Inc Transaction History

Brand Asset Management Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $85,256 - $94,586	-365 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $23,300 - $27,153	105 Added 40.38%	365 $91,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $5,866 - $6,523	25 Added 10.64%	260 $66,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $5,102 - $6,767	-28 Reduced 10.65%	235 $48,000
Q1 2019 Apr 25, 2019	BUY	$180.87 - $203.88 $5,064 - $5,708	28 Added 11.91%	263 $50,000
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $39,021 - $43,829	235 New	235 $43,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Brand Asset Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Brand Asset Management Group, Inc. with notifications on news.